GLOBAL CANCER TREATMENT DRUGS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 136

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
The worldwide market for Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Roche
- Novartis
- Celgene
- Bristol-Myers Squibb
- Amgen
- Johnson & Johnson
- Pfizer
- Takeda
- Eli Lilly
- AstraZeneca
- Astellas
- Merck & Co.
- Sanofi
- Bayer
- Biogen Idec
- Eisai
- Teva
- Otsuka
- Merck KGaA
- Ipsen
- AbbVie
- Gilead Sciences

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy (Biologic Therapy)
- Others

Market Segment by Applications, can be divided into
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other Cancers

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Treatment Drugs, with price, sales, revenue and global market share of Cancer Treatment Drugs in 2017 and 2018.
Chapter 3, the Cancer Treatment Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Mar 20)

Market Overview The global Artesunate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Plant Sources Anti Cancer Agents market size is expected to gain market growth in the forecast period of 2...

(Mar 20)

Market Overview The global Hydroxycamptothecin market size is expected to gain market growth in the forecast period of 2020 to 2025, ...

(Mar 20)

Market Overview The global Irinotecan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Medical Protective Packaging market size is expected to gain market growth in the forecast period of 2020 ...

(Mar 20)

Market Overview The global Vinorelbine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a C...

GLOBAL CANCER TREATMENT DRUGS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy